Results 101 to 110 of about 84,630 (297)
ABSTRACT While targeted therapies have improved outcomes in lung adenocarcinoma (LUAD), many patients still lack targetable mutations. Here, we identified alpha‐L‐fucosidase 2 (FUCA2) as a crucial driver of LUAD by preventing cellular senescence. Mechanistically, through the restriction of fucosyltransferase 3 (FUT3)‐mediated α‐1,3‐fucosylation of ...
Lu Chen +18 more
wiley +1 more source
First German-speaking harm reduction conference in Vienna
The first Harm Reduction DACH Conference [DACH = D (Germany), A (Austria), CH (Switzerland)] took place in Vienna on June 23rd, 2023, and focused on tobacco harm reduction.
Larissa Steimle +5 more
doaj +1 more source
Rediscovering cytisine: Why the WHO’s decision matters for global public health
Summary: Recently, the World Health Organization (WHO) announced the inclusion of cytisine in its Model List of Essential Medicines (EMLs). Owing to its efficacy, tolerability profile, and low cost, cytisine represents a valuable addition to the smoking ...
Riccardo Polosa, Gal Cohen
doaj +1 more source
TaMYB7‐A1 directly activates TaABI5 to enhance ABA signaling and regulate ABA‐GA homeostasis, enforcing seed dormancy. Its superior allele, derived from wild einkorn introgression, harbors a MITE insertion that elevates expression and two amino acid substitutions that enhance transcriptional activity, collectively generating graded PHS resistance for ...
Hao Wang +18 more
wiley +1 more source
The role of smoke-free alternatives to cigarettes for tobacco harm reduction remains controversial. This study was conducted to understand the perspectives of a panel of Italian experts on this topic.
Pasquale Caponnetto +5 more
doaj +1 more source
The Concept of Harm Reduction from Tobacco: Past, Present, Future
The concept of tobacco harm reduction (THR) is a speculative and controversial topic in the context of the international battle against the use of all types of tobacco.
M. V. Gorbunova +3 more
core +1 more source
Dysregulated TCA cycle contributes to Alzheimer's disease (AD) pathogenesis. Here, we show that microglial isocitrate dehydrogenase 1 (IDH1) is a critical driver. Elevated IDH1 disrupts citrate metabolism and mitochondrial function, exacerbating AD pathology.
Qianqian Li +13 more
wiley +1 more source
What Do We Know About Smoking Alternatives? A Study on IQOS Tobacco Heaters
Introduction Nicotine addiction poses a significant public health concern in Poland, exacerbated by smoking, e-cigarettes, and heated tobacco products.
Filip Nadolny +7 more
doaj +1 more source
Patient–physician communication regarding electronic cigarettes
Introduction: Smokers are likely asking their physicians about the safety of e-cigarettes and their potential role as a cessation tool; however, the research literature on this communication is scant.
Michael B. Steinberg +2 more
doaj +1 more source
Understanding the emergence of the tobacco industry's use of the term tobacco harm reduction in order to inform public health policy [PDF]
Objectives: To explore the history of transnational tobacco companies’ use of the term, approach to and perceived benefits of ‘harm reduction’. Methods: Analysis of internal tobacco industry documents, contemporary tobacco industry literature and 6 ...
Peeters, Silvy +3 more
core +1 more source

